Rectal-wall dose dependence on postplan timing after permanent-seed prostate brachytherapy.

[1]  W. Butler,et al.  Rectal dosimetric analysis following prostate brachytherapy. , 1999, International journal of radiation oncology, biology, physics.

[2]  F M Waterman,et al.  Effect of post-implant edema on the rectal dose in prostate brachytherapy. , 1999, International journal of radiation oncology, biology, physics.

[3]  The effect of constipation on rectal dosimetry following prostate brachytherapy. , 2000 .

[4]  S Nag,et al.  The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. , 2000, International journal of radiation oncology, biology, physics.

[5]  L. Potters,et al.  Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer. , 2000, International journal of radiation oncology, biology, physics.

[6]  R. Stock,et al.  Defining the risk of developing grade 2 proctitis following 125I prostate brachytherapy using a rectal dose-volume histogram analysis. , 2001, International journal of radiation oncology, biology, physics.

[7]  K. Wallner,et al.  Dosimetric and radiographic correlates to prostate brachytherapy‐related rectal complications , 2001, International journal of cancer.

[8]  K. Wallner,et al.  American Brachytherapy Society recommendations for reporting morbidity after prostate brachytherapy. , 2002, International journal of radiation oncology, biology, physics.

[9]  A. Dicker,et al.  Impact of postimplant edema on V(100) and D(90) in prostate brachytherapy: can implant quality be predicted on day 0? , 2002, International journal of radiation oncology, biology, physics.

[10]  C. Catton,et al.  Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation. , 2002, International journal of radiation oncology, biology, physics.

[11]  K. Wallner,et al.  Rectal function following brachytherapy with or without supplemental external beam radiation: results of two prospective randomized trials. , 2003, Brachytherapy.

[12]  Adam P Dicker,et al.  Probability of late rectal morbidity in 125I prostate brachytherapy. , 2003, International journal of radiation oncology, biology, physics.

[13]  M. Kattan,et al.  Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  Patrick W McLaughlin,et al.  The use of mutual information in registration of CT and MRI datasets post permanent implant. , 2004, Brachytherapy.

[15]  Ivan Yeung,et al.  Sequential evaluation of prostate edema after permanent seed prostate brachytherapy using CT-MRI fusion. , 2004, International journal of radiation oncology, biology, physics.

[16]  L. Potters,et al.  Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk. , 2005, Brachytherapy.

[17]  Caitlin Gillan,et al.  Posttreatment Complications of Early‐Stage Prostate Cancer Patients: Brachytherapy Versus Three‐Dimensional Conformal Radiation Therapy , 2005, Cancer journal.